Cigarette Smoking Has no Impact on the Effect of Radioiodine Therapy in Patients with Graves Disease
Journal Title: Acta Facultatis Medicae Naissensis - Year 2015, Vol 32, Issue 1
Abstract
Presently, there is very little data on the impact of nicotine and other components of tobacco smoking on the outcome of radioiodine therapy (RIT) in Graves’ disease (GD). Thus, this study was aimed to analyze a possible impact of cigarette smoking on the effect of radioiodine therapy in the patients with Graves’ disease. The study included 31 patients (16 smokers and 15 non-smokers) with GD, aged from 22 to 73 years, who were treated with a single dose of iodine-131 sodium iodide (131I-NaI) and subjected to a 12-month follow-up, thereafter. Patients were treated with antithyroid drugs (ATDs) before RIT and described very intense stressful events occurring prior to diagnosing Graves’ hyperthyroidism. A successful response to RIT was defined as euthyroidism and subclinical or clinical hypothyroidism, while an unsuccessful response was defined as persistent hyperthyroidism. Comparison of age (47.4±9.41 vs. 49.5±13.8 years, p=0.628) at the time of RIT, applied activity of 131I-NaI (372±78.4 vs. 363±43.7 MBq, p=0.675), and duration of ATDs therapy (3.47±3.33 vs. 4.94±5.62 years, p=0.387) between smokers and non-smokers showed no significant difference. The cumulative incidence of successful response to therapy in smokers and non-smokers was 31.2 vs. 46.7% (p<0.05), 50.0 vs. 60.0% (p>0.05), 56.2 vs. 60.0% (p>0.05), and 56.2 vs. 66.7% (p>0.05) after 3, 6, 9 and 12 months, respectively. The results showed that cigarette smoking has no impact on the effect of radioiodine therapy after twelve-month period in patients who had experienced stressful events before the occurrence of Graves’ disease. However, patients with smoking habits achieved successful response later than non-smokers.
Authors and Affiliations
Vladan Sekulić, Milena Rajić, Marina Vlajković, Slobodan Ilić, Miloš Stević, Ivana Mišić, Milan Božinović
Keywords
Related Articles
- EP ID EP153138
- DOI 10.1515/afmnai-2015-0007
- Views 97
- Downloads 0
Congenital Posteromedial Bowing of the Tibia: A Single Center Experience - - - Kongenitalna posteromedijalna angulacija tibije: iskustva jednog centra
Congenital posteromedial bowing of the tibia (CPMBT) is a rare congenital anomaly of the lower limbs. The aim of the present study was to analyze our experience in the treatment of CPMBT. A retrospective study of patient...
BIODOSTUPNOST TEŠKIH METALA IZ ZEMLJIŠTA RAZLIČITIH LOKALITETA ZA MEDICINSKO BILJE
Pored pozitivnog efekta koje mogu imati po ljudski organizam, pojedine lekovite biljke, kao i njihove mešavine, mogu predstavljati rizik po zdravlje usled prisustva toksičnih metala kao što su Pb i Cd. Do kontaminacije l...
Traumatic Intrahepatic Biloma – A Rare Entity Mimicking Neoplasm of the Liver: A Case Report
Bilomas represent large collections of bile, produced due to a rupture of bile ducts. Most frequently, they are located in the perihepatic tissues, rarely intrahepatic ones. Usually, bile ducts rupture is caused by traum...
Using Team-Based Learning to Teach Evidence-Based Medicine to First-Year Residents
Team-based learning (TBL) is a well-established instructional strategy that provides students with the chance to apply conceptual knowledge through a series of actions, including pre-class, individual, team class activit...
CANCER OF UNKNOWN PRIMARY SITE SYNDROME- CUP SYNDROME - DIAGNOSTIC AND THERAPEUTICAL DILLEMAS
Metastatic carcinomas of unknown primary origin (cancer of unknown primary-CUP) represent 3-5% of all cancers. This term includes all patients presented with metastatic disease in whom the primary site could not have bee...